Cargando…
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
AIMS/HYPOTHESIS: Multiplex proteomics could improve understanding and risk prediction of major adverse cardiovascular events (MACE) in type 2 diabetes. This study assessed 80 cardiovascular and inflammatory proteins for biomarker discovery and prediction of MACE in type 2 diabetes. METHODS: We combi...
Autores principales: | Nowak, Christoph, Carlsson, Axel C., Östgren, Carl Johan, Nyström, Fredrik H., Alam, Moudud, Feldreich, Tobias, Sundström, Johan, Carrero, Juan-Jesus, Leppert, Jerzy, Hedberg, Pär, Henriksen, Egil, Cordeiro, Antonio C., Giedraitis, Vilmantas, Lind, Lars, Ingelsson, Erik, Fall, Tove, Ärnlöv, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061158/ https://www.ncbi.nlm.nih.gov/pubmed/29796748 http://dx.doi.org/10.1007/s00125-018-4641-z |
Ejemplares similares
-
Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach
por: Carlsson, Axel C., et al.
Publicado: (2019) -
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
por: Nowak, Christoph, et al.
Publicado: (2016) -
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?
por: Skau, Emma, et al.
Publicado: (2023) -
The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population
por: Stenemo, Markus, et al.
Publicado: (2019) -
Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes
por: Carlsson, Axel C., et al.
Publicado: (2016)